Effects of a low-salt diet on flow-mediated dilatation in humans

American Journal of Clinical Nutrition

Volumn 89, Issue 2, 2009, Pages 485-490

  Dickinson, Kacie M ^a,b   Keogh, Jennifer B ^a,b   Clifton, Peter M ^a  

^a CSIRO   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM; SATURATED FATTY ACID; SODIUM;

ADULT; AGED; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; BLOOD VESSEL FUNCTION; BODY WEIGHT; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; DIETARY INTAKE; FAT CONTENT; FEMALE; FLOW MEDIATED DILATATION; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MALE; OBESITY; POTASSIUM INTAKE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SALT INTAKE; SODIUM EXCRETION; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; VASCULAR ENDOTHELIUM;

ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; DIET, SODIUM-RESTRICTED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PULSATILE FLOW; SODIUM; SODIUM CHLORIDE, DIETARY; SYSTOLE; VASODILATION;

EID: 59649123418     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.26856     Document Type: Article

References (52)

1. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993;21:1145-51.
2. Hashimoto M, Akishita M, Eto M, et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord 1998;22:477-84.
3. Anderson TJ, Gerhard MD, Meredith IT, et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 1995;75:71B-4B.
4. Raitakari OT, Celermajer DS. Flow-mediated dilatation. Br J Clin Pharmacol 2000;50:397-404.
5. Shimbo D, Grahame-Clarke C, Miyake Y, et al. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 2007;192:197-203.
6. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007;115:2390-7.
7. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-41.
8. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
9. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997;30:325-33.
10. Dishy V, Sofowora GG, Imamura H, et al. Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses. J Hypertens 2003;21:153-7.
11. Keogh JB, Brinkworth GD, Noakes M, Belobradjic DP, Buckley JD, Clifton PM. Effects of weight loss from a very low carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr 2008;87:567-76.
12. Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003;34:1203-6.
13. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Dia-betologia 2008;51:527-39.
14. Polonia J, Maldonado J, Ramos R, et al. Estimation of salt intake by urinary sodium excretion in a Portuguese adult population and its relationship to arterial stiffness. Rev Port Cardiol 2006;25:801-17.
15. Avolio AP, Clyde KM, Beard TC, Cooke HM, Ho KK, O'Rourke MF. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986;6:166-9.
16. Whelton PK, He J. Potassium in preventing and treating high blood pressure. Semin Nephrol 1999;19:494-9.
17. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodila-tion of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65.
18. van Trijp MJ, Beulens JW, Bos WJ, et al. Alcohol consumption and augmentation index in healthy young men: the ARYA study. Am J Hypertens 2005;18:792-6.
19. Boegehold MA. Reduced influence of nitric oxide on arteriolar tone in hypertensive Dahl rats. Hypertension 1992;19:290-5.
20. Boegehold MA. Microvascular structure and function in salt-sensitive hypertension. Microcirculation 2002;9:225-41.
21. Luscher TF, Raij L, Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 1987;9:157-63.
22. Matsuoka H, Itoh S, Kimoto M, et al. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 1997;29:242-7.
23. Nava E, Luscher TF. Endothelium-derived vasoactive factors in hypertension: nitric oxide and endothelin. J Hypertens Suppl 1995;13:S39-48.
24. Raij L, Luscher TF, Vanhoutte PM. High potassium diet augments endothelium-dependent relaxations in the Dahl rat. Hypertension 1988;12:562-7.
25. Bragulat E, de la Sierra A. Salt intake, endothelial dysfunction, and salt-sensitive hypertension. J Clin Hypertens (Greenwich) 2002;4:41-6.
26. Fujiwara N, Osanai T, Kamada T, Katoh T, Takahashi K, Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation 2000;101:856-61.
27. Fang Y, Mu JJ, He LC, Wang SC, Liu ZQ. Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supple-mentin normotensive salt-sensitive Asians. Hypertension 2006;48:724-9.
28. Matrougui K, Levy BI, Schiavi P, Guez D, Henrion D. Indapamide improves flow-induced dilation in hypertensive rats with a high salt intake. J Hypertens 1998;16:1485-90.
29. Mervaala EM, Malmberg L, Teravainen TL, et al. Influence of different dietary salts on the cardiovascular and renal effects of moxonidine in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol 1997;356:107-14.
30. Kagota S, Tamashiro A, Yamaguchi Y, et al. Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats. Br J Pharmacol 2001;134:737-44.
31. Forstermann U, Mulsch A, Bohme E, Busse R. Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res 1986;58:531-8.
32. Koesling D, Friebe A. Soluble guanylyl cyclase: structure and regulation. Rev Physiol Biochem Pharmacol 1999;135:41-65.
33. Kagota S, Tamashiro A, Yamaguchi Y, Nakamura K, Kunitomo M. High salt intake impairs vascular nitric oxide/cyclic guanosine monophos-phate system in spontaneously hypertensive rats. J Pharmacol Exp Ther 2002;302:344-51.
34. Davison K, Coates AM, Buckley JD, Howe PR. Effect of cocoa flava-nols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes (Lond) 2008;32:1289-96.
35. Liu LS, Zheng DY, Jin L, Liao YL, Liu K, Stamler J. Variability of urinary sodium and potassium excretion in north Chinese men. J Hy-pertens 1987;5:331-5.
36. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 1991;18:67-71.
37. Jurgens G, Graudal NA. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database Syst Rev 2004;CD004022.
38. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007;334:885.
39. Jula AM, Karanko HM. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation 1994;89:1023-31.
40. Frohlich ED, Varagic J. The role of sodium in hypertension is more complex than simply elevating arterial pressure. Nat Clin Pract Car-diovasc Med 2004;1:24-30.
41. Ahn J, Varagic J, Slama M, Susic D, Frohlich ED. Cardiac structural and functional responses to salt loading in SHR. Am J Physiol Heart Circ Physiol 2004;287:H767-72.
42. Yu HC, Burrell LM, Black MJ, et al. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998;98:2621-8.
43. Blake J, Devereux RB, Borer JS, Szulc M, Pappas TW, Laragh JH. Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension. Am J Med 1990;88:477-85.
44. Daniels SD, Meyer RA, Loggie JM. Determinants of cardiac involvement in children and adolescents with essential hypertension. Circulation 1990;82:1243-8.
45. du Cailar G, Ribstein J, Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 2002;15:222-9.
46. Schmieder RE, Messerli FH, Ruddel H, et al. Sodium intake modulates left ventricular hypertrophy in essential hypertension. J Hypertens Suppl 1988;6:S148-50.
47. Broadley AJ, Korszun A, Abdelaal E, et al. Inhibition of cortisol production with metyrapone prevents mental stress-induced endothelial dysfunction and baroreflex impairment. J Am Coll Cardiol 2005;46:344-50.
48. Kerstens MN, van der Kleij FG, Boonstra AH, et al. Salt loading affects cortisol metabolism in normotensive subjects: relationships with salt sensitivity. J Clin Endocrinol Metab 2003;88:4180-5.
49. Ho JT, Keogh JB, Bornstein SR, et al. Moderate weight loss reduces renin and aldosterone but does not influence basal or stimulated pituitary-adrenal axis function. Horm Metab Res 2007;39:694-9.
50. Rogers KM, Bonar CA, Estrella JL, Yang S. Inhibitory effect of glu-cocorticoid on coronary artery endothelial function. Am J Physiol Heart Circ Physiol 2002;283:H1922-8.
51. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236-41.
52. Nurnberger J, Keflioglu-Scheiber A, Opazo Saez AM, Wenzel RR, Philipp T, Schafers RF. Augmentation index is associated with cardiovascular risk. J Hypertens 2002;20:2407-14.